In vitro monitoring of clindamycin in human urine using flow injection chemiluminescence

Abstract.

A sensitive chemiluminescence method for the determination of clindamycin is presented. The method is based on the inhibitory effect of clindamycin on the chemiluminescence reaction between luminol and myoglobin in a flow-injection system. The decrement in chemiluminescence intensity is linear with the logarithm of the clindamycin concentration over the range of 0.1–70.0 ng mL⁻¹ (r ² = 0.9995), with a detection limit of 0.03 ng mL⁻¹ (3σ). At a flow rate of 2.0 mL min⁻¹, the complete analytical process could be performed within 0.5 min, including sampling and washing, with a relative standard deviation of less than 3.0% (n = 5). The procedure was applied to the determination of clindamycin in human serum and in monitoring the excretion of clindamycin in human urine samples without any pretreatment process. It was found that the excretive clindamycin concentration reached its maximum 3 hours after oral administration. The clindamycin excretive ratio in 9 hours was 10.84% in the body of the volunteer.